Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James, Christine Jenkins, Matthew Peters, Guy B. Marks, Melissa Baraket, Heather Powell, Jodie L. Simpson
Format: Artigo
Language:English
Published: 2019
Online Access:https://doi.org/10.1183/23120541.00056-2019
https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!